IDBS becomes the first Electronic Lab Notebook provider to achieve SOC 2 compliance IDBS has achieved compliance with SOC 2, following an audit by CyberGuard Compliance, LLC to the American Institute of Certified Public Accountants’ (AICPA) Trust Services Criteria…
We sat down with Christian Marcazzo, General Manager at IDBS, to find out what the benefits of attending i3 are, and how it fits into his vision for IDBS. What are some of the benefits to customers attending the i3…
The biopharmaceutical industry continues to grow and isn’t showing any signs of slowing down. Last year, we talked about different aspects of the biopharmaceutical industry. These touched on several trends from the importance of data and the extensive use…
IDBS enables research and innovation (R&I) teams to accelerate data capture, analysis and scientific decision-making and reduce the time to market of innovative, cost-effective new products to millions of customers worldwide. You can find out more about our approach to…
eBook Why Focus on Your Inventory? On average, labs manage up to 1 million samples1. The inventory store of samples can be one of the most valuable and expensive assets in any research and development (R&D) lab. A report by…
Webinar | Presented on 22 Aug 2019Date & Time: Thursday, August 22, 2019 @ 11:00 AM – 12:00 PM EST Duration: 60 minutes Host: Brady Haggstrom Learning Objectives Understand the marketplace factors driving cloud technology in Life Sciences What the benefit…
We sat down with J.T. Kaminski, Customer Success Manager at IDBS, to find out what i3 means to IDBS, and what he sees for the event’s future. What’s the most eye-opening thing you’ve seen at i3 last year? I’d…
Eighty-five. That’s the number of warning letters the FDA issued in 2018 alone. And of those letters, 49% were surrounding data integrity. This highlights a serious issue: there are data integrity deficiencies in the lab environment. With so many warning…
eBook Tackling Rising Costs and Reducing Time to Market Having broken global sales records in the past, biopharmaceutical companies are now seeing consistent industry growth and have been valued at billions of dollars in 20181. A study from 2016 has…
We sat down with Brady Haggstrom, Product Manager at IDBS, to find out what i3 means, and its highlights. What do you look forward to most about coming to i3 events? I look forward most to talking with customers and hearing about their challenges, what…
